290 E John Carpenter Fwy
Irving, TX, 75062
9728300000

https://www.vizientinc.com/

 

Company Profile

Alliance members, log in to view this company's complete profile.

Demographics

Year Licensed:
Accreditation Type: ,
Number of Employees:
Health Plan Profit Status: ,
Health Plan Tax Status:

Alliance Company Type: Shareholder
Alliance Member Since: 6/30/1996
Alliance Shareholder Since: 6/30/1996
CMS Regional Office:

Articles
4/3/2018

Former executive at PwC, Baylor Scott & White Health and Healthvision named president and CEO of Vizient
Vizient, Inc. ("Vizient") announces that Byron Jobe, its previous president, chief administrative and financial officer, is the new president and CEO of the Company. This announcement is the result of a multi-year succession plan that has been thoughtfully developed and executed by Vizient's Board.

1/14/2018

Washington Update - January 12, 2018
Congress has a full agenda and is planning for multiple key personnel changes. 340B has dominated the news and there are already several new regulations and much, much more!!

12/22/2017

Washington Update - December 22, 2017
This end of year special edition is short and "sweet" as possible to share what Congress has been up to until the very last second.

12/11/2017

Washington Update - December 4, 2017
Congress is rapidly advancing a tax reform package that includes major health care provisions, while still facing a lengthy list of other must do’s (such as funding the government, reauthorizing CHIP and more) and a very unclear end game. A nominee to be the new HHS secretary started his confirmation hearings; there is an abundance of regulatory activity, and so much more. So let’s get to it!

11/13/2017

Vizient Washington Update
Despite opposition from bipartisan majorities in the House and Senate, Medicare advisory councils, and widespread concerns from hospitals, CMS went ahead and finalized a 28.5% Medicare cut for 340B eligible hospitals. We have several other final rules, a tax bill, an opioid public health emergency and recommendations from a Presidential Commission, the House moving on CHIP and IPAB, some MedPAC hearings and ACA open-enrollment!